武肺疫情輾轉覆轍,加上唔少人士直到依一刻依然唔信武肺存在,又或者唔怕武肺唔戴口罩、「我生病我的事」,導致感染人數經常出現技術性反彈。485Please respect copyright.PENANAnKPE3uis8y
485Please respect copyright.PENANAuxoFY4kwBj
武肺疫苗一直被媒體渲染為扭轉全球疫情的唯一辦法,但實際上一直黑過黑森林的黑馬一直在漆黑中默默奔跑,隨時會跑快過各種疫苗率先進入市場。485Please respect copyright.PENANAC8dvEkJxUN
485Please respect copyright.PENANAEjmnBgCpUR
依一隻黑馬,就係人造抗體。485Please respect copyright.PENANAJqEZGwqXaR
485Please respect copyright.PENANA5VDa9CMsLr
疫苗的最終目的,就係想誘導人體自行製造抗體,達收拾武肺之效。485Please respect copyright.PENANAbMjwjOOeNr
485Please respect copyright.PENANAlU4DvFZer7
有唔少生物科技公司認為,與其花費時間製造疫苗,倒不如以人造的方式製作疫苗的最終產物「抗體」,豈不是更加直接快捷?485Please respect copyright.PENANAul9WVz5sjn
485Please respect copyright.PENANAdZGDZ3M22w
就喺今年六月初,禮來公司(Lilly)宣佈進行人造抗體LY-Cov555的Phase1臨床測試(Ref1),LY-Cov555係一隻針對武肺S protein位置的人造抗體,簡單啲嚟講,佢主要功用就係黏住武肺病毒與人體細胞的接觸面,令到病毒無辦法辨認細胞,失去入侵人體細胞的手段。485Please respect copyright.PENANAIoXTQspjck
485Please respect copyright.PENANAUbWam7WY8e
除禮來之外,雷傑納榮製藥(Regeneron)亦宣佈即將會進行Phase3臨床試驗,佢哋將會以人造方式製造一名武肺康復人士的抗體再加以一隻由老鼠而嚟的武肺抗體,用上二合一的方式進行測試(Ref2)。485Please respect copyright.PENANAMBRjapekJP
485Please respect copyright.PENANAGg0IZX8QzR
佢哋所製作的人造抗體有學術文章指出,將能夠辨認得到現今的所有武肺變種,包括時下大流行的D614G變種,聽起上嚟的確非常令人振奮。485Please respect copyright.PENANAK9xAGyS2c7
485Please respect copyright.PENANAQqdw4T1HMf
而最值得注意的係,人造抗體的臨床治療所需時間一般會比疫苗的臨床治療為快。原因係就疫苗嚟講,通常要一定的時間過後身體免疫系統先會開始製造抗體,隨後先可以進行測試。485Please respect copyright.PENANAvwTh1MZ1WH
485Please respect copyright.PENANA9Drtmxg9vV
但人造抗體只要一注射入體內,有就有,無就無,相對上好快就可以進行所需的測試。485Please respect copyright.PENANATHcrKTbvYV
485Please respect copyright.PENANAleWohtB40c
所以呢,人造抗體依一隻黑馬,絕對係有機會跑快過疫苗進入商業市場的。485Please respect copyright.PENANAqfxJQVGLJo
485Please respect copyright.PENANAMt9UNae4nM
不過當然,論長遠嚟講,疫苗絕對比人造抗體更能提供更長遠及實際的保護效果。485Please respect copyright.PENANApzCiaJnUTR
但就當今現時局勢嚟講,疫苗某程度上只係「遠水」,人造抗體先係「近水」,有效撲滅武肺「近火」。485Please respect copyright.PENANAUQybUuHtTx
485Please respect copyright.PENANAfU2uut2BT5
485Please respect copyright.PENANAXZxEF1tjQD
某兩款康復病人對抗武肺抗體(綠色及橙色)的示意圖,白色為武肺與人體細胞接觸所需的S protein。裡頭的紅點及藍點為現今所知的武肺變種位置,無一個變種位置可以阻撓抗體與其結合。485Please respect copyright.PENANAEU0xSlYDj4
485Please respect copyright.PENANAw0dHj6iLxG
Ref1: https://investor.lilly.com/news-releases/news-release-details/lilly-begins-worlds-first-study-potential-covid-19-antibody485Please respect copyright.PENANAGlx3IgGMKi
Ref2: https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-start-regn-cov2-phase-3-covid-19-prevention/485Please respect copyright.PENANAkGhOAr3hgK
arrow_back
科普專欄–薯不揀單
more_vert
-
info_outline Info
-
toc Table of Contents
-
share Share
-
format_color_text Display Settings
-
exposure_plus_1 Recommend
-
Sponsor
-
report_problem Report
-
account_circle Login
Search stories, writers or societies
Continue ReadingClear All
What Others Are ReadingRefresh
X
Never miss what's happening on Penana!
科普專欄–薯不揀單
Author:
薯仔聞茱莉
ISSUE #14
<<抵抗武肺的黑馬–人造抗體>>
LIKES 1
READS 481
BOOKMARKS 148
campaign
Request update 0
Sponsor
Login with Facebook
or Sign up/Login to comment or bookmark!
Click to load the next chapter
X
After each update request, the author will receive a notification!
smartphone100 → Request update
X
Sponsor again
Click to login
Login first to show your name as a sponsor.
Thank you for supporting the story! :)
Please Login first.
×
Write down what you like about the story
×
Reading Theme:
Font Size:
Line Spacing:
Paragraph Spacing:
Load the next issue automatically
Reset to default
×
People Who Like This